Found 51 matching trials
Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults
PHASE1The purpose of the study is to evaluate the safety, tolerability, and immun...
Location
Brigham and Women's Hospital
Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/Ib
PHASE1P27A study is designed as a randomized phase Ia/Ib trial to evaluate the sa...
The Effects of GLA (5 mcg) on Human Volunteers
PHASE1This protocol is for a phase 1, randomized, single-blinded study to evaluat...
Location
Rockefeller University
TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery
PHASE1This pilot phase I clinical trial studies the side effects and best dose of...
Location
Fred Hutch/University of Washington Cancer Consortium
Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults
PHASE1The purpose of this study is to evaluate the safety, tolerability, and immu...
A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma
PHASE1This is a single arm, open-label, single center study evaluating the safety...
Location
University of Washington Medical Center, Seattle Cancer Care Alliance
Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers
PHASE2The purpose of this study is to evaluate the experimental tuberculosis (TB)...
Location
Ajou University Hospital
Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants
PHASE1This study evaluated the safety and immune response in healthy HIV-exposed ...
Location
Perinatal HIV Research Unit (PHRU), Soweto CRS
Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults
PHASE2The purpose of the study is to evaluate the safety, tolerability, and immun...
Location
Brigham and Women's Hospital
A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer
PHASE1This is a Phase I, multi-center, multiple ascending dose study to evaluate ...
Location
Scottsdale Healthcare